TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age.

Jean-François Roussy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.